Hepatotoxicity Case Due to Interferon Beta-1A Use
Akademik Gastroenteroloji Dergisi(2023)
摘要
Interferon β-1a is an immunomodulatory drug widely used in the treatment of multiple sclerosis. Liver dysfunction is a common side effect of this drug and usually develops within the first 6 months of starting interferon therapy. Here, we present our case who developed hepatotoxicity secondary to interferon β-1a treatment.
更多查看译文
关键词
Hepatotoxicity,Drug-Induced Liver Injury
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要